Description
Composition- Sitagliptin 50 mg + Metformin 500 mg
Mode of Action- Combines DPP-4 inhibition with metformin-mediated reduction in hepatic glucose output and improved insulin sensitivity for effective dual glycemic control.
USPs- Balanced dual antidiabetic therapy; useful in early to moderate type 2 diabetes; supports fasting and postprandial glucose control.
Prescribing Specialties- Diabetologist, General Physician, Internal Medicine
